Condition: Depression Mild · Depression · Depression Moderate · Sponsor: Stanford University
Study will utilize an app, Matter Neuroscience, designed to help users with depression understand positive emotions and the neurotransmitters that create them. We hope to learn the safety and efficacy of neurofeedback for treating depression and lay the groundwork for a pivotal clinical trial.
This description comes directly from the study's public registry record.
Stephanie Wan · 650 491 6339 · stephwan@stanford.edu
Nick Bassano · 650-800-6920 · nbassano@stanford.edu
Always discuss trial participation with your own doctor first.
| Stanford University Brain Stimulation Lab | Stanford, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06735885